Search Within

Steven M Horwitz

  1. "Bone Marrow Transplant"
Formats
  1. Meeting Abstract (32)
  2. Journal Article (15)
  3. Review (1)
Groups
  1. Bone Marrow Transplant (48)
  2. Center for Hematologic Malignancies (48)
  3. Department of Medicine (48)
  4. Hematologic Malignancies, Division of (48)
  5. Lymphoma (48)
  6. Population Sciences Research Program (48)

More Groups

People
  1. Alison Moskowitz (40)
  2. Andrew Zelenetz (31)
  3. Craig Sauter (29)
  4. Ariela Noy (28)
  5. Matthew Matasar (27)
  6. Anita Kumar (25)

More People

Years
  1. 2023 (2)
  2. 2022 (3)
  3. 2021 (6)
  4. 2020 (4)
  5. 2019 (6)
  6. 2018 (2)

More Years

Publications
  1. Blood (28)
  2. Hematological Oncology (3)
  3. Journal of Clinical Oncology (3)
  4. Leukemia and Lymphoma (3)
  5. Blood Advances (2)
  6. Clinical Lymphoma, Myeloma and Leukemia (2)

More Publications

Publishers
  1. American Society of Hematology (30)
  2. American Society of Clinical Oncology (3)
  3. Elsevier Inc. (3)
  4. Taylor & Francis Group (3)
  5. Wiley Blackwell (3)
  6. Nature Publishing Group (2)

More Publishers

Results (48)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Responses and outcomes after second-line therapy in transplant-eligible patients with DLBCL relapse over 1 year after first-line therapy
    Meeting Abstract

    Qualls, D. A.; Shah, G. L.; Shouval, R.; Caron, P.; David, K. A.; Falchi, L.; Ghione, P.; Hamlin, P. A.; Horwitz, S. M.; Intlekofer, A. M.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Cumulative incidence of myeloid neoplasms in patients with nodal T-follicular helper cell lymphoma
    Meeting Abstract

    Stuver, R.; Ganesan, N.; Dogan, A.; Epstein-Peterson, Z. D.; Ghione, P.; Johnson, W.; Lewis, N.; Moskowitz, A.; Shah, G. L.; Scordo, M.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Immune signature of pembrolizumab plus gemcitabine, vinorelbine, and liposomal doxorubicin as second-line therapy for relapsed or refractory classical Hodgkin lymphoma
    Meeting Abstract

    Wills, B.; Ganesan, N.; Shah, G. L.; Wong, P.; Argyropoulos, K. V.; Sen, F.; Dogan, A.; Straus, D. J.; Noy, A.; Kumar, A.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Outcomes for patients with relapsed and refractory peripheral T-cell lymphoma in the 21st century by relapse status, salvage therapy, and receipt of allogeneic transplant
    Meeting Abstract

    Stuver, R.; Epstein-Peterson, Z. D.; Johnson, W. T.; Khan, N.; Sauter, C. S.; Scordo, M.; Shah, G. L.; Moskowitz, A. J.; Horwitz, S. M.
    Blood (2022)

    Fulltext@MSK | Save
  • Current treatment of peripheral T-cell lymphoma
    Review

    Stuver, R.; Epstein-Peterson, Z. D.; Johnson, W. T.; Khan, N.; Lewis, N.; Moskowitz, A. J.; Sauter, C. S.; Horwitz, S. M.
    Oncology (Norwalk) (2022)

    Fulltext@MSK | Save
  • TP53 mutations identify high-risk peripheral T-cell lymphoma patients treated with CHOP-based chemotherapy
    Meeting Abstract

    Johnson, W. T.; Ganesan, N.; Epstein-Peterson, Z. D.; Maccaro, C.; Galasso, N.; Sauter, C. S.; Neuman, R.; Khan, N.; Moskowitz, A. J.; Dogan, A.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Impact of choice of platinum-based salvage therapy on CNS relapse in patients with relapsed or refractory diffuse large B-cell lymphoma
    Meeting Abstract

    Buege, M. J.; Dao, P.; Dematteo, R. G.; LeVoir, A.; Pak, T.; Batlevi, C. L.; Hamilton, A.; Hamlin, P. A.; Horwitz, S. M.; Joffe, E.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Update of a phase II, multicenter study of high-dose chemotherapy with autologous stem cell transplant followed by maintenance romidepsin for T-cell lymphoma
    Meeting Abstract

    Khan, N.; Khimani, F.; Shustov, A. R.; Shadman, M.; Ruan, J.; Moskowitz, A. J.; Straus, D. J.; Kumar, A.; Sauter, C. S.; Zelenetz, A. D.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Phase II trial of pembrolizumab plus gemcitabine, vinorelbine, and liposomal doxorubicin as second-line therapy for relapsed or refractory classical Hodgkin lymphoma
    Journal Article

    Moskowitz, A. J.; Shah, G.; Schòˆder, H.; Ganesan, N.; Drill, E.; Hancock, H.; Davey, T.; Perez, L.; Ryu, S.; Sohail, S.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Outcomes of adult T-cell leukemia/lymphoma with allogeneic stem cell transplantation: Single-institution experience
    Journal Article

    Epstein-Peterson, Z. D.; Ganesan, N.; Barker, J. N.; Drullinsky, P. R.; Ghione, P.; Jakubowski, A. A.; Kumar, A.; Moskowitz, A. J.; Noy, A.; Perales, M. A.; more...
    Leukemia and Lymphoma (2021)

    Fulltext@MSK | Save